| Department | Title | Author | Short Description | Video Url |
|---|---|---|---|---|
| Pharmacy | Titel ORAL THIN FILMS (OTF) | LTS Lohmann Therapie-Systeme AG (EN) | Oral thin films are a modern dosage form that enable rapid and precisely dosed delivery of active ingredients without the need of supplementary water. Our video gives insights how OTFs are designed and how they work. | View |
| Pharmacy | Oral thin films – a new evolution step for active substances | LTS Lohmann Therapie-Systeme AG (EN) | Oral thin films contain the active substance as a film, which is taken orally and is dissolved immediately in the mouth or applied to the mucosa. For transmucosal films, the active substance enters the bloodstream directly via the oral mucosa, without having to first pass through the gastrointestinal tract. | View |
| Pharmacy | Gene Delivery Systems for Gene Therapy – Creative Biolabs | Creative Biolabs | One of the key steps in gene therapy is to deliver foreign genes or gene editing systems into target tissues or cells. Thus efficient gene delivery system is very important to the effect of gene therapy. We discussed the gene delivery systems that commonly used in research and clinic, and our gene delivery system development services. | View |
| Pharmacy | Gene Therapy | Types of gene therapy | Applications of gene therapy | Dr. Neeraj Kumar | In this video, you will learn about: 1. Gene therapy and it’s types. 2. Virus mediated and Direct methods of gene delivery. 3. Applications, advantages and disadvantages of gene therapy. 4. Major achievements of gene therapy. 5. Future prospects of gene therapy. | View |
| Pharmacy | Pharmaceutical Regulatory Affairs | NPTEL – Special Lecture Series | Regulatory Affairs- RA, in a Pharmaceutical industry, is a profession which acts as the interface between the pharmaceutical industry and Drug Regulatory authorities and Ministry of Health across the world. It is mainly involved in the registration of the API, Finished Pharmaceuticals, Medical Device etc in India and Global countries prior to their marketing. The Regulatory Affairs- RA Department, Act as a liaison with Global Regulatory Agencies and Ministry of Health for Product Registration . It Involves Preparation of organized and scientifically valid Technical DOSSIERS which adheres and is compliant with all the applicable cGMP, ICH, GCP, GLP guidelines, regulations and laws. Providing expertise and regulatory intelligence in translating regulatory requirements into practical workable plans. Advising the companies on regulatory aspects and climate that would affect their proposed activities. Apart from the above main roles, there are various other roles which Regulatory Affairs professionals play. Proficiency in Regulatory Affairs has high Career Prospects for budding Pharmacy Students. | View |
| Pharmacy | Regulatory and Clinical Affairs Alumni Career Paths 2021 | UCSF Office of Career and Professional Development | Regulatory and Clinical Affairs Alumni Career Paths Panel featuring UCSF alums Patrick Heiser, PhD and Brandi Saunders, MS in conversation with Michael Matrone, PhD, associate director, the Office of Career and Professional Development at UCSF. Recorded as part of the Every Month Series. November 2021. | View |
| Pharmacy | How to work in Regulatory Affairs (Drug and Medical Devices) | Easy Medical Device | How long to be ready to work in Regulatory affairs? What are the important skills to have to be a good professional? Is the transition from one regulatory field to another difficult to do? She will really provide us all her knowledge on this and also give us some information about TOPRA. This organization can help you to perform this transition and also to improve on your Regulatory Affairs career. | View |
| Pharmacy | The US Drug Master File Process | Regis Technologies, Inc. | Jennifer Stanek describes the US drug master file process at a seminar hosted by Regis Technologies, inc | View |
| Pharmacy | GDUFA II Training – Pre ANDA Program Pre Submission Meetings, Robert Lionberger | Food and Drug Administration | The pre-ANDA program is new in GDUFA II and it’s designed to accelerate access to generic versions of complex products. Meetings between FDA and ANDA applicants are a critical step toward meeting these goals. | View |
| Pharmacy | Specialty spotlight – clinical pharmacology and therapeutics | Royal College of Physicians | Listen to Dr Reecha Sofat, Senior Lecturer, UCL and Honorary Consultant in Clinical Pharmacology and Therapeutics, UCLH discuss her specialty with Dr James Fullerton, NIHR Clinical Lecturer, UCL and Specialist Registrar in Clinical Pharmacology and Therapeutics, UCLH. | View |
WEBSITE DISCLAIMER
Last updated: 2022-06-15
The information provided by STM Journals (“Company”, “we”, “our”, “us”) on https://journals.stmjournals.com/ (the “Site”) is for general informational purposes only. All information on the Site is provided in good faith, however, we make no representation or warranty of any kind, express or implied, regarding the accuracy, adequacy, validity, reliability, availability, or completeness of any information on the Site.
UNDER NO CIRCUMSTANCE SHALL WE HAVE ANY LIABILITY TO YOU FOR ANY LOSS OR DAMAGE OF ANY KIND INCURRED AS A RESULT OF THE USE OF THE SITE OR RELIANCE ON ANY INFORMATION PROVIDED ON THE SITE. YOUR USE OF THE SITE AND YOUR RELIANCE ON ANY INFORMATION ON THE SITE IS SOLELY AT YOUR OWN RISK.
EXTERNAL LINKS DISCLAIMER
The Site may contain (or you may be sent through the Site) links to other websites or content belonging to or originating from third parties or links to websites and features. Such external links are not investigated, monitored, or checked for accuracy, adequacy, validity, reliability, availability, or completeness by us.
WE DO NOT WARRANT, ENDORSE, GUARANTEE, OR ASSUME RESPONSIBILITY FOR THE ACCURACY OR RELIABILITY OF ANY INFORMATION OFFERED BY THIRD-PARTY WEBSITES LINKED THROUGH THE SITE OR ANY WEBSITE OR FEATURE LINKED IN ANY BANNER OR OTHER ADVERTISING. WE WILL NOT BE A PARTY TO OR IN ANY WAY BE RESPONSIBLE FOR MONITORING ANY TRANSACTION BETWEEN YOU AND THIRD-PARTY PROVIDERS OF PRODUCTS OR SERVICES.
PROFESSIONAL DISCLAIMER
The Site can not and does not contain medical advice. The information is provided for general informational and educational purposes only and is not a substitute for professional medical advice. Accordingly, before taking any actions based on such information, we encourage you to consult with the appropriate professionals. We do not provide any kind of medical advice.
Content published on https://journals.stmjournals.com/ is intended to be used and must be used for informational purposes only. It is very important to do your analysis before making any decision based on your circumstances. You should take independent medical advice from a professional or independently research and verify any information that you find on our Website and wish to rely upon.
THE USE OR RELIANCE OF ANY INFORMATION CONTAINED ON THIS SITE IS SOLELY AT YOUR OWN RISK.
AFFILIATES DISCLAIMER
The Site may contain links to affiliate websites, and we may receive an affiliate commission for any purchases or actions made by you on the affiliate websites using such links.
TESTIMONIALS DISCLAIMER
The Site may contain testimonials by users of our products and/or services. These testimonials reflect the real-life experiences and opinions of such users. However, the experiences are personal to those particular users, and may not necessarily be representative of all users of our products and/or services. We do not claim, and you should not assume that all users will have the same experiences.
YOUR RESULTS MAY VARY.
The testimonials on the Site are submitted in various forms such as text, audio, and/or video, and are reviewed by us before being posted. They appear on the Site verbatim as given by the users, except for the correction of grammar or typing errors. Some testimonials may have been shortened for the sake of brevity, where the full testimonial contained extraneous information not relevant to the general public.
The views and opinions contained in the testimonials belong solely to the individual user and do not reflect our views and opinions.
ERRORS AND OMISSIONS DISCLAIMER
While we have made every attempt to ensure that the information contained in this site has been obtained from reliable sources, STM Journals is not responsible for any errors or omissions or the results obtained from the use of this information. All information on this site is provided “as is”, with no guarantee of completeness, accuracy, timeliness, or of the results obtained from the use of this information, and without warranty of any kind, express or implied, including, but not limited to warranties of performance, merchantability, and fitness for a particular purpose.
In no event will STM Journals, its related partnerships or corporations, or the partners, agents, or employees thereof be liable to you or anyone else for any decision made or action taken in reliance on the information in this Site or for any consequential, special or similar damages, even if advised of the possibility of such damages.
GUEST CONTRIBUTORS DISCLAIMER
This Site may include content from guest contributors and any views or opinions expressed in such posts are personal and do not represent those of STM Journals or any of its staff or affiliates unless explicitly stated.
LOGOS AND TRADEMARKS DISCLAIMER
All logos and trademarks of third parties referenced on https://journals.stmjournals.com/ are the trademarks and logos of their respective owners. Any inclusion of such trademarks or logos does not imply or constitute any approval, endorsement, or sponsorship of STM Journals by such owners.
Use of AI Tools in Blog Content
Some of the blog posts published on this website are created with the assistance of Artificial Intelligence (AI) tools. While efforts are made to review and edit the content for accuracy and appropriateness, there may still be instances where unintended, unnecessary, or unverified information or claims appear.Readers are advised to use their discretion while interpreting the content. The primary purpose of using AI-generated content is to provide our audience with the most recent, diverse, and wide-ranging information on various topics. The content is intended to inform and engage, not to mislead.All external links included in the blogs are intended to guide users to real and authentic workshops, programs, or resources. The information presented through those links is curated and verified to the best of our knowledge.This disclaimer is meant to inform visitors about the use of AI in content creation, acknowledge potential limitations in content accuracy, and encourage informed and responsible reading.
CONTACT US
Should you have any feedback, comments, requests for technical support, or other inquiries, please contact us by email: [email protected].